Advertisement

Topics

Savaria Announces 2016 Second Quarter Results Release Date

20:00 EDT 26 Jul 2016 | Marketwired

LAVAL, QUEBEC -- (Marketwired) -- 07/27/16 -- Savaria Corporation ("Savaria") (TSX: SIS), one of North America's leaders in the accessibility industry, will release its 2016 second quarter results after market hours on August 10th, 2016.

Savaria Corporation (savaria.com) is one of North America's leaders in the accessibility industry. It provides accessibility solutions for the elderly and physically-challenged to increase their mobility and independence. The diversity of its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts, as well as elevators for home and commercial use. In addition, it converts and adapts vehicles to be wheelchair accessible. It also operates a network of franchisees and corporate stores through which new and recycled accessibility equipment is sold. Savaria operates a plant located in Huizhou (China), which increases its competitive edge. The Corporation records more than 60% of its revenue outside Canada, primarily in the United States. It operates a sales network of some 400 active retailers in North America and employs some 500 people. Its principal places of business are located in Laval (Quebec), Brampton (Ontario) and Huizhou (China).

Facebook: https://www.facebook.com/savariabettermobility

Twitter: https://twitter.com/Mobilityforlife

Contacts: Helene Bernier, CPA, CA Vice-President, Finance 1-800-931-5655, ext. 248 Marcel Bourassa President and Chief Executive Officer 1-800-661-5112 NEXT ARTICLE

More From BioPortfolio on "Savaria Announces 2016 Second Quarter Results Release Date "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...